# GBS Ventures: portfolio, investments and team

> GBS Ventures is a vc firm based in Australia. 40 investments on record, latest May 2015. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/gbs-venture-partners (Millionrounds; every figure on the page links to its filing or article)

Australia · [Investor](https://millionrounds.com/investors)

# GBS Ventures

Last cheque observed May 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Quiet VC firm

Seed Series A Series B Enterprise Software Marketing Venture Capital & Private Equity

Follow GBS Ventures and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fgbs-venture-partners)

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 40 on record

Since the last cheque **4195** days **00** hrs **00** min **00** sec

Median round **$11M** Rounds led **0 of 40** Sole investor **2 rounds** Exits **2 from the portfolio** Mostly in **United States, 85%**

Pitch GBS Ventures

## GBS Ventures highlights

- 01 40 rounds on record
- 02 Mostly Series A and Venture: 54% of its rounds
- 03 Sole investor in 2 rounds, median $5.0M
- 04 2 exits from the portfolio

## What they do

> The homepage text does not explicitly describe the organisation's investment activities; the name 'GBS Venture Partners' suggests a venture capital firm, but no supporting text is provided. From their own website

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth
- **Sectors:** Enterprise Software Marketing Venture Capital & Private Equity
- **Based in:** Melbourne, Australia
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **40 appearances**

- **2015** 1 round
- **May** **[Moximed](https://millionrounds.com/company/moximed)** Series B · US **$33M** With 4 others
- **2014** 5 rounds
- **Sept** **[Ivantis](https://millionrounds.com/company/ivantis)** Series B · US **$25M** With 7 others
- **Sept** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Series E · US **$1.0M** With 3 others
- **Apr** **[Spinifex Pharmaceuticals](https://millionrounds.com/company/spinifex-pharmaceuticals)** Series C · GB **$45M** With 4 others
- **Apr** **[Neurovance](https://millionrounds.com/company/neurovance)** Series A · US **$6.3M** With 6 others
- **Jan** **[Ivantis](https://millionrounds.com/company/ivantis)** Series B · US **$14M** With 5 others
- **2013** 1 round
- **Jun** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Series E · US · t.co **$9.0M** With 3 others
- **2012** 7 rounds
- **Jul** **[CoDa Therapeutics](https://millionrounds.com/company/coda-therapeutics)** Series B · US · finsmes.com **$20M** With 2 others
- **May** **[Hatchtech](https://millionrounds.com/company/hatchtech)** Venture · AU · pevc.dowjones.com **$8.1M** With 2 others
- **Apr** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Series D · US **$11M** With 4 others
- **Mar** **[Uptake Medical](https://millionrounds.com/company/uptake-medical)** Series C · US · sec.gov **$40M** With 6 others
- **Feb** **[Celladon](https://millionrounds.com/company/celladon)** Venture · US · finsmes.com **$43M** With 5 others
- **Jan** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Series D · US · researchviews.com **$1.1M** With 2 others
- **Jan** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Growth · US **$10M** With 4 others
- **2011** 6 rounds
- **Aug** **[Spinifex Pharmaceuticals](https://millionrounds.com/company/spinifex-pharmaceuticals)** Series B · AU · spinifexpharma.com.au **$19M** With 2 others
- **May** **[Pathway Therapeutics](https://millionrounds.com/company/pathway-therapeutics)** Series A · US · pathwaytx.com **$7.5M** With 1 other
- **Apr** **[CoDa Therapeutics](https://millionrounds.com/company/coda-therapeutics)** Series B · US · pehub.com **$19M** With 2 others
- **Mar** **[Euthymics Bioscience](https://millionrounds.com/company/euthymics-bioscience)** Series A · US · masshightech.com **$4.0M** With 3 others
- **Mar** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Venture · US · bizjournals.com **$3.0M** With 1 other
- **Mar** **[AirXpanders](https://millionrounds.com/company/airxpanders)** Venture · US · bizjournals.com **$5.0M** Sole investor
- **2010** 7 rounds
- **Aug** **[NeuroVista](https://millionrounds.com/company/neurovista)** Venture · US · neurovista.com **$17M** With 3 others
- **Aug** **[Nuon Therapeutics](https://millionrounds.com/company/nuon-therapeutics)** Venture · US · bizjournals.com **$10M** With 2 others
- **Aug** **[Pathway Therapeutics](https://millionrounds.com/company/pathway-therapeutics)** Series A · US · pathwaytx.com **$4.5M** With 2 others
- **Jul** **[Euthymics Bioscience](https://millionrounds.com/company/euthymics-bioscience)** Series A · US · euthymics.com **$24M** With 1 other
- **Jul** **[Uptake Medical](https://millionrounds.com/company/uptake-medical)** Series B · US · uptakemedical.com **$18M** With 5 others
- **Apr** **[Xenome](https://millionrounds.com/company/xenome)** Venture · AU · xenome.com **$10M** With 1 other
- **Mar** **[Nuon Therapeutics](https://millionrounds.com/company/nuon-therapeutics)** Venture · US · deals.venturebeat.com **$6.0M** With 2 others
- **2009** 1 round
- **Oct** **[Pathway Therapeutics](https://millionrounds.com/company/pathway-therapeutics)** Series A · US · pathwaytx.com **$2.4M** With 1 other
- **2008** 4 rounds
- **Dec** **[KaloBios Pharmaceuticals](https://millionrounds.com/company/kalobios-pharmaceuticals)** Series D · US · kalobios.com **$12M** With 7 others
- **Sept** **[KaloBios Pharmaceuticals](https://millionrounds.com/company/kalobios-pharmaceuticals)** Series D · US **$20M** With 8 others
- **Jun** **[Pathway Therapeutics](https://millionrounds.com/company/pathway-therapeutics)** Series A · US · pathwaytx.com **$9.6M** With 1 other
- **May** **[NovaSys](https://millionrounds.com/company/novasys)** Venture · US · deals.venturebeat.com **$50M** With 10 others
- **2007** 3 rounds
- **Jul** **[Nuon Therapeutics](https://millionrounds.com/company/nuon-therapeutics)** Series A · US · nuontherapeutics.com **$5.0M** Sole investor
- **Mar** **[Phenomix](https://millionrounds.com/company/phenomix)** Series C · US · phenomixcorp.com **$55M** With 10 others
- **Feb** **[Proacta](https://millionrounds.com/company/proacta)** Series B · US **$35M** With 6 others
- **2006** 1 round
- **Oct** **[CoDa Therapeutics](https://millionrounds.com/company/coda-therapeutics)** Series A · US · codatherapeutics.com **$10M** With 1 other
- **2005** 2 rounds
- **Oct** **[OPAL Therapeutics](https://millionrounds.com/company/opal-therapeutics)** Series A · AU · lifescientist.com.au **$6.0M** With 3 others
- **May** **[Hatchtech](https://millionrounds.com/company/hatchtech)** Venture · AU · goliath.ecnext.com **$2.2M** With 4 others
- **2004** 1 round
- **Apr** **[NOVASYS MEDICAL](https://millionrounds.com/company/novasys-medical)** Series C · US **$25M** With 6 others
- **2002** 1 round
- **Mar** **[Phenomix](https://millionrounds.com/company/phenomix)** Series A · US **$12M** With 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **3** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What they claim to have backed

From their own portfolio page (on their website)

**15** of 31 we have independently watched raise

[AirXpanders](https://millionrounds.com/company/airxpanders)[Celladon](https://millionrounds.com/company/celladon)[Elastagen](https://millionrounds.com/company/elastagen)[Endoluminal Sciences](https://millionrounds.com/company/endoluminal-sciences)[Hatchtech](https://millionrounds.com/company/hatchtech)[Ivantis](https://millionrounds.com/company/ivantis)[Moximed International, Inc](https://millionrounds.com/company/moximed)[NeuroVista](https://millionrounds.com/company/neurovista)[Neurovance](https://millionrounds.com/company/neurovance)[Novasys](https://millionrounds.com/company/novasys)[Proacta](https://millionrounds.com/company/proacta)[Sunshine Heart](https://millionrounds.com/company/sunshine-heart)[Uptake Medical](https://millionrounds.com/company/uptake-medical)[Viveve](https://millionrounds.com/company/viveve)[Xenome](https://millionrounds.com/company/xenome) AiMedics Applied Physiology CoDa CogState Dynamic Hearing Euthymics Health Hydrexia Kalobios Mimetica Neuromonics Pacific Knowledge Systems Peplin Spinifex Verva Pharmaceuticals evolution 7

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## Exits from the portfolio

Companies it backed that were later bought or listed **2 in all**

**[Spinifex Pharmaceuticals](https://millionrounds.com/company/spinifex-pharmaceuticals)** Bought by [Novartis](https://millionrounds.com/fund/novartis) **$200M** Jun 2015

**[KaloBios Pharmaceuticals](https://millionrounds.com/company/kalobios-pharmaceuticals)** Listed **Undisclosed** Jan 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Seed Series A Series B

Median round joined **$11M** the round, not its cheque Alone, median **$5.0M**

Led 0 of 40 rounds **0%**

- **Sole investor:** 2 rounds
- **Last cheque:** May 2015
- **Exits:** 2 from the portfolio

Rounds by stage said on their site

- Series A said *11*
- Venture *10*
- Series B said *8*
- Series C *4*
- Series D *4*
- Series E *2*
- Seed said *-*

Cheques by year Led Joined

2002 2015

Often in the room with

- [Delphi Ventures](https://millionrounds.com/fund/delphi-ventures) 7
- [Alloy Ventures](https://millionrounds.com/fund/alloy-ventures) 5
- [CM Capital Investments](https://millionrounds.com/fund/cm-capital-investments) 5
- [Domain Associates](https://millionrounds.com/fund/domain-associates) 5
- [Prolog Ventures](https://millionrounds.com/fund/prolog-ventures) 5
- [Vivo Ventures](https://millionrounds.com/fund/vivo-ventures) 5

**Pitching GBS Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as GBS Ventures. A count of rooms they were both in, not a relationship either has claimed.

[**Delphi Ventures** VC firm **7** rounds together](https://millionrounds.com/fund/delphi-ventures)[**Alloy Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/alloy-ventures)[**CM Capital Investments** Investment firm **5** rounds together](https://millionrounds.com/fund/cm-capital-investments)[**Domain Associates** VC firm **5** rounds together](https://millionrounds.com/fund/domain-associates)[**Prolog Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/prolog-ventures)[**Vivo Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/vivo-ventures)[**Affinity Capital Management** VC firm **4** rounds together](https://millionrounds.com/fund/affinity-capital-management)[**Alta Partners** VC firm **4** rounds together](https://millionrounds.com/fund/alta-partners)[**Novartis Venture Fund** Corporate VC **4** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**ONSET Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/onset-ventures)[**Sofinnova Investments** VC firm **4** rounds together](https://millionrounds.com/fund/sofinnova-investments)[**Uniseed Pty** Investment firm **4** rounds together](https://millionrounds.com/fund/uniseed-pty)

## Quick answers about GBS Ventures

### What does GBS Ventures invest in?

GBS Ventures invests most often at Series A and Venture (54% of the rounds on record), in sectors such as Enterprise Software, Marketing and Venture Capital & Private Equity.

### How active is GBS Ventures?

40 investments on record, 0 of them in the last 12 months. The most recent was in May 2015.

### How big are GBS Ventures's cheques?

The median round it joins is $11M.

### Does GBS Ventures lead rounds?

Rarely, if at all: none of its 40 investments on record names it as the lead.

### Where does GBS Ventures invest?

Most of the companies it backs are in the United States (85%) and Australia (13%).

### Is GBS Ventures investing now?

No investments in the last 12 months; the latest was in May 2015.

### Who does GBS Ventures invest alongside?

Most often Delphi Ventures (7 rounds together), Alloy Ventures (5 rounds together) and CM Capital Investments (5 rounds together).

### What kind of investor is GBS Ventures?

GBS Ventures is a VC firm based in Melbourne, Australia.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=gbs-venture-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=gbs-venture-partners)